News

Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss

Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market.This approval and launch add to Teva’s ...
Technology Networks3d

First Generic GLP-1 for Obesity Gains FDA Approval

Teva Pharmaceuticals has launched the first generic GLP-1 drug for weight loss in adults and adolescents; a lower-cost ...

Did FDA Approval of Generic Saxenda Just Shift Teva's (TEVA) Investment Narrative?

Teva Pharmaceuticals announced in late August 2025 that it received FDA approval and commenced the U.S. launch of its generic version of Saxenda® (liraglutide injection), which had annual sales of ...
NJBIZ1d

Teva wins FDA nod for first generic GLP-1 weight-loss drug

Teva Pharmaceuticals gained FDA approval to launch the first generic GLP-1 drug for weight loss, a liraglutide injection based on Saxenda.
The Pharma Letter2d

Teva to offer first US generic GLP-1 specifically for weight loss

Israeli drugmaker Teva Pharmaceutical Industries has announced US Food and Drug Administration (FDA) approval and launch of a ...

I tried to lose weight on Mounjaro but was bleeding & in constant pain – then found a cheaper way with zero side effects

IT was when Gillian Coia saw herself in a new photo that something finally clicked. Topping the scales at 15.5 stone, the ...
Medical Dialogues6d

USFDA approves Teva Pharma generic Saxenda for weight loss

Parsippany: Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd., has announced the FDA approval and U.S. launch of a generic version of Saxenda ...

TEVA Trumpets Saxenda, Stocks Eke Higher

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) said its U.S. affiliate announced today the FDA approval and U.S. launch of a generic version of Saxenda®1 (liraglutide injection). “With this approval ...
Managed Healthcare Executive6d

Teva Launches First Generic GLP-1 Drug for Obesity

Teva Pharmaceuticals has received FDA approval and has launched a generic version of Saxenda (liraglutide), which is approved to treat adults and adolescents 12 to 17 years of age who are obese or ...

Obesity drug prescriptions surpass 1.1 million, raising misuse concerns

More than 1.1 million prescriptions for the weight-loss drugs Saxenda and Wegovy have been issued in South Korea over the ...

Protect yourself against fake pharmacies flogging Mounjaro – as expert reveals 6 red flags before buying fat jabs online

AS fat jab users panic and race to stock up on Mounjaro, a sharp rise in fake pharmacies will be capitalising on users’ money ...

Teva stock rises on launch of first generic weight loss GLP-1 drug

Investing.com -- Teva Pharmaceutical Industries Ltd ADR (NYSE:TEVA) stock rose 2.7% after the company announced FDA approval and U.S. launch of its generic version of Saxenda (liraglutide injection), ...